Search hospitals > Ontario > TORONTO
Princess Margaret Cancer Centre
Claim this profileTORONTO, Ontario M5G 2M9
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Prostate Cancer
Conducts research for Solid Tumors
Conducts research for Non-Small Cell Lung Cancer
988 reported clinical trials
71 medical researchers
Summary
Princess Margaret Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Tumors, Prostate Cancer, Solid Tumors, Non-Small Cell Lung Cancer and other specialties. Princess Margaret Cancer Centre is involved with conducting 988 clinical trials across 433 conditions. There are 71 research doctors associated with this hospital, such as Amit Oza, MD, Lillian Siu, MD, Marcus Butler, and Philippe Bedard.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Tumors
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Amit Oza, MDPrincess Margaret Cancer Centre4 years of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
28 reported clinical trials
47 drugs studied
Lillian Siu, MDPrincess Margaret Cancer Centre8 years of reported clinical research
Studies Cancer
Studies Breast Cancer
16 reported clinical trials
39 drugs studied
Marcus ButlerPrincess Margaret Cancer Centre7 years of reported clinical research
Studies Melanoma
Studies Bladder Cancer
14 reported clinical trials
25 drugs studied
Philippe BedardPrincess Margaret Cancer Centre3 years of reported clinical research
Studies Tumors
Studies Breast Cancer
15 reported clinical trials
26 drugs studied
Clinical Trials running at Princess Margaret Cancer Centre
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Multiple Myeloma
Ovarian Cancer
Tumors
Lung Cancer
Plasma Cell Neoplasms
Endometrial Cancer
Ovarian Suppression Therapy
for Breast Cancer
This trial tests TOL2506, a treatment that stops ovaries from working, in premenopausal women and men with hormone-sensitive breast cancer. It aims to reduce hormone levels to slow down or stop cancer growth. TOL2506 is a treatment that stops ovaries from working, similar to other ovarian suppression methods.
Recruiting2 awards Phase 39 criteria
Virtual Rehabilitation
for Cancer Survivors
Pragmatic hybrid type 1 effectiveness-implementation (E-I) trial of a virtual cancer rehabilitation program: The study team will conduct a multi-center hybrid type I effectiveness-implementation study to examine the clinical effectiveness and implementation potential of an 8-week multidimensional virtual cancer rehabilitation intervention (CaRE@Home) for cancer survivors with identified cancer-related impairments on level of overall disability (primary outcome) and patient reported physical and social functioning, anxiety, work status, quality of life, and physiologic changes (secondary outcomes). The study team will conduct a multi-centre pragmatic randomized controlled trial (RCT) (Vancouver, Toronto, Saint John and St. John's) to evaluate effectiveness and using the CIFR, the study team will identify potential factors that may affect successful implementation and integration of CaRE@Home in different cancer settings.
Recruiting1 award N/A8 criteria
Short-Course Radiation Therapy
for Breast Cancer
Breast-conserving surgery followed by re-irradiation with partial breast irradiation (rPBI) has recently been found to be a safe alternative to mastectomy for women who have undergone prior whole breast radiation. By reducing the volume of tissue receiving radiation, rPBI has been associated with less toxicity and improved cosmetic outcomes. For many women with early stage breast cancer, shorter 1-week (5-fraction) courses of breast radiation (ultra-fractionation) have been found to be equivalent to longer fractionation schedules in the upfront treatment setting. These 1-week schedules are more convenient for patients, with fewer treatments and shorter overall treatment time. The investigators hypothesize that they can accrue sufficient patient with rPBI who will be treated using 26 Gray(Gy) in 5 daily fractions over 1-week. Planned interim analysis after the 15 recruited patients for early toxicity evaluation with stopping rule for unacceptable toxicity.
Recruiting1 award N/A8 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Princess Margaret Cancer Centre?
Princess Margaret Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Tumors, Prostate Cancer, Solid Tumors, Non-Small Cell Lung Cancer and other specialties. Princess Margaret Cancer Centre is involved with conducting 988 clinical trials across 433 conditions. There are 71 research doctors associated with this hospital, such as Amit Oza, MD, Lillian Siu, MD, Marcus Butler, and Philippe Bedard.
Where is Princess Margaret Cancer Centre located?
**Princess Margaret Cancer Centre Location and Access:**
- **Address:** 610 University Ave, Toronto, ON M5G 2M9.
- **Public Transport:** Accessible via Queen's Park subway station on Line 1, 506 Carlton or 505 Dundas streetcars. The 142 bus provides additional service along University Avenue during rush hours.
- **Drop-off Points:** Murray Street entrance and University Avenue entrance, both wheelchair accessible.
Who should I call to ask about financial aid or insurance network?
The Princess Margaret Cancer Centre offers comprehensive financial assistance and insurance support for patients through various programs:
- **Income Assistance Programs**: Patients can consult a social worker or contact the Psychosocial Oncology clinic at 416-946-4525.
- **Canadian Breast Cancer Support Fund**: Provides up to $1000 for expenses such as transportation, parking, food, home health, prosthetics, supportive care, and rent.
- **Kelly Shires Breast Cancer Foundation**: Offers up to $1000 for similar expenses to those diagnosed with breast cancer.
- **Canadian Cancer Society’s Travel Treatment Fund**: Assists with travel costs based on a financial assessment.
- **Wellspring's Money Matters**: Connects patients with financial counselling for income replacement and drug compensation.
- **Power of Hope Cost Reduction Program**: Aids cancer patients under 40 with fertility preservation treatment costs.
- **POGO Financial Assistance Program**: Supports Ontario families with expenses like accommodation, food, and child care for siblings under 12 during the child's cancer treatment.
- For general inquiries, contact The Princess Margaret Cancer Foundation at 416-946-6560 or toll-free at 1-866-224-6560.
What insurance does Princess Margaret Cancer Centre accept?
The Princess Margaret Cancer Centre accepts Canadian insurance plans, including OHIP and private insurance. OHIP covers most cancer treatment costs, while some expenses might need coverage through private insurance, government programs, or income tax claims. International patients should refer to the UHN International Patient Program (IPP), and private cancer care services may require a referral and can be covered by private insurance or self-pay.
What awards or recognition has Princess Margaret Cancer Centre received?
The Princess Margaret Cancer Centre, located in Toronto, Ontario, is among the top five cancer research centers globally, renowned for its groundbreaking research and exceptional patient care. It boasts a comprehensive clinical trials program, offering numerous trials for different cancer types, with its database frequently updated. The center's innovative work and life-saving research are supported by the Invest in Research program, enhancing its capability to transform patient outcomes worldwide.